Health Care

According to a new survey, 90% of employees admit they have come into the office despite knowing they are sick—an increase of 10% from last year. Here are three signs you are better off staying home.

Teva Pharmaceutical’s chief executive Jeremy Levin abruptly stepped down from his role at the Israeli drug maker on Wednesday.

Pfizer reported better-than-expected third-quarter earnings helped by cost cuts and growing sales of recently approved cancer medicines.

New intelligent bionics and exoskeletons are expected to one day help patients who haven’t used their lower bodies in years.

When old medical debt is keeping you from moving ahead with your life, it's time to take action. 

Hundreds of thousands of children die from Malaria each year, but new research could help catch deadly diseases before they reach maturity.

The medical device maker reported improved earnings in the third quarter despite lagging sales of pacemakers and backed its full-year outlook.

To save as much as $2 billion a year, Teva Pharmaceutical said Thursday it was expanding its cost-cutting program by axing 10% of its workforce.

The moves are aimed at slimming down the global drug giant and narrowing its focus.

Oncolytics reported that its experimental lung cancer drug shrunk tumors in 92% of patients in a study.

Oncolytics reported that its experimental lung cancer drug shrunk tumors in 92% of patients in a study.

Isis Pharmaceuticals has once again joined forces with Biogen Idec to advance the treatment for neurological disorders.

Amgen said over the weekend it would  buy cancer drug maker Onyx Pharmaceuticals  for about $10.4 billion in one of the biggest-ever biotech deals.

St. Jude Medical agreed to buy Endosense for up to $230 million, providing it with catheter technologies that can be used during heart surgeries.

While health-related devices have yet to cause any catastrophes, the FDA and CIS are being proactive in trying to stop an attack before it happens.

Shares of MannKind climbed after the company revealed positive late-stage trial results for its experimental drug for type 1 and type 2 diabetes.

The biotech giant revealed positive results for a late-stage trial of a drug being investigated as a treatment for lung cancer.

Chronic disease challenges both health and wallet. Is there a way to cure the steep costs?

CVS Caremark's 2Q profit rose slightly more than expected, as profit growth at the pharmacy benefits management unit helped buoy modest improvements at the drugstores. 

All doctors aren’t created equal so it’s critical that people check out the credentials of their physician to ensure they’re getting the best treatment.